#ESCCongress | Diretrizes 2021 da ESC para diagnóstico e tratamento de insuficiência cardíaca aguda e crônica – Inibidores de SGLT2 agora são recomendados para pacientes com insuficiência cardíaca e fração de ejeção reduzida independentemente da presença de diabetes.

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC – European Heart Journal

Comunicado de imprensa: ESC Guidelines on heart failure management launched today – European Society of Cardiology

Comentário no Twitter

The new heart failure guidelines by @escardio https://t.co/NRvxh8UUxp ready for #ESCCongress https://t.co/NlGYM9DAqA enjoy reading 128 pages. Some important figures pic.twitter.com/6GmRUuSw9z

— rafavidalperez (@rafavidalperez) August 27, 2021